Featured Research

from universities, journals, and other organizations

Females may be more susceptible to infection during ovulation

Date:
January 4, 2012
Source:
Federation of American Societies for Experimental Biology
Summary:
A woman's ovarian cycle plays a role in susceptibility to infection, according to new research. Specifically, researchers found women are most susceptible to infection, such as Candida albicans or other sexually transmitted diseases, during ovulation than at any other time during the reproductive cycle. This natural "dip" in immunity may be to allow spermatozoa to survive the threat of an immune response so it may fertilize an egg successfully.

A new research report in the Journal of Leukocyte Biology suggests that a woman's ovarian cycle plays an important role in her susceptibility to infection. Specifically, researchers from Spain and Austria found that women are most susceptible to infection, such as Candida albicans or other sexually transmitted diseases, during ovulation than at any other time during the reproductive cycle. This natural "dip" in immunity may be to allow spermatozoa to survive the threat of an immune response so it may fertilize an egg successfully.

"This could be an explanation why during ovulation females have more risk of being infected with sexual transmitted diseases like HIV or HPV," said Miguel Relloso, Ph.D., a researcher involved in the work from the Laboratorio de Inmunobiologํa Molecular at the Hospital Gregorio Mara๑๓n and Complutense University in Madrid, Spain.

Using mice, Relloso and colleagues found that the sex hormone, estradiol, increased susceptibility to systemic candidiasis (fungal infection). To monitor the effect of estradiol treatment on infection, researchers used in vivo and ex vivo fungal infection models. Ovariectomized mice were treated with estradiol and subsequently pulsed with C. albicans. Estradiol-treated mice were more susceptible to the fungal infection and had lower Th17 immune response. The researchers identified dendritic cells as a target cells of estradiol and showed that estradiol treated dendritic cells were inefficient at triggering the Th17 immune response to C. albicans antigens.

"The next time you hear a woman say that she's sick of men," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology, "you can add this to her list as another reason. This adaption which allows male sperm to survive long enough to fertilize an egg, may also open the door for other types of infection."


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. Relloso, L. Aragoneses-Fenoll, S. Lasarte, C. Bourgeois, G. Romera, K. Kuchler, A. L. Corbi, M. A. Munoz-Fernandez, C. Nombela, J. L. Rodriguez-Fernandez, R. Diez-Orejas. Estradiol impairs the Th17 immune response against Candida albicans. Journal of Leukocyte Biology, 2011; 91 (1): 159 DOI: 10.1189/jlb.1110645

Cite This Page:

Federation of American Societies for Experimental Biology. "Females may be more susceptible to infection during ovulation." ScienceDaily. ScienceDaily, 4 January 2012. <www.sciencedaily.com/releases/2012/01/120103135333.htm>.
Federation of American Societies for Experimental Biology. (2012, January 4). Females may be more susceptible to infection during ovulation. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/01/120103135333.htm
Federation of American Societies for Experimental Biology. "Females may be more susceptible to infection during ovulation." ScienceDaily. www.sciencedaily.com/releases/2012/01/120103135333.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins